Regulus Therapeutics Inc (RGLS)
2.00
-0.02
(-0.99%)
USD |
NASDAQ |
May 16, 16:00
2.00
0.00 (0.00%)
Pre-Market: 09:11
Regulus Therapeutics 1 Year Total Returns (Daily): 37.93% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 16, 2024 | 37.93% |
| May 15, 2024 | 30.32% |
| May 14, 2024 | 19.20% |
| May 13, 2024 | 19.77% |
| May 10, 2024 | 47.33% |
| May 09, 2024 | 59.57% |
| May 08, 2024 | 65.81% |
| May 07, 2024 | 58.72% |
| May 06, 2024 | 72.95% |
| May 03, 2024 | 103.8% |
| May 02, 2024 | 107.7% |
| May 01, 2024 | 93.08% |
| April 30, 2024 | 72.28% |
| April 29, 2024 | 88.76% |
| April 26, 2024 | 79.26% |
| April 25, 2024 | 66.91% |
| April 24, 2024 | 63.26% |
| April 23, 2024 | 67.41% |
| April 22, 2024 | 62.96% |
| April 19, 2024 | 71.77% |
| April 18, 2024 | 80.49% |
| April 17, 2024 | 91.80% |
| April 16, 2024 | 115.1% |
| April 15, 2024 | 133.6% |
| April 12, 2024 | 211.1% |
| Date | Value |
|---|---|
| April 11, 2024 | 189.6% |
| April 10, 2024 | 177.6% |
| April 09, 2024 | 184.7% |
| April 08, 2024 | 181.5% |
| April 05, 2024 | 161.9% |
| April 04, 2024 | 170.7% |
| April 03, 2024 | 199.2% |
| April 02, 2024 | 220.9% |
| April 01, 2024 | 230.4% |
| March 28, 2024 | 246.8% |
| March 27, 2024 | 263.2% |
| March 26, 2024 | 198.9% |
| March 25, 2024 | 196.3% |
| March 22, 2024 | 158.2% |
| March 21, 2024 | 164.8% |
| March 20, 2024 | 174.5% |
| March 19, 2024 | 174.1% |
| March 18, 2024 | 171.3% |
| March 15, 2024 | 74.38% |
| March 14, 2024 | 100.4% |
| March 13, 2024 | 97.56% |
| March 12, 2024 | 87.30% |
| March 11, 2024 | 9.52% |
| March 08, 2024 | 1.46% |
| March 07, 2024 | 3.65% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.89%
Minimum
Jun 07 2019
297.7%
Maximum
Mar 22 2021
-20.06%
Average
-33.33%
Median
Sep 25 2020
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals Inc | -32.13% |
| Cassava Sciences Inc | -14.72% |
| Vertex Pharmaceuticals Inc | 27.67% |
| Cormedix Inc | 16.59% |
| Oragenics Inc | -43.06% |